Health Condition 1: H53- Visual disturbances
Conditions
Interventions
Intervention1: Occlusion therapy for unilateral amblyopia.: Occlusion therapy for patients aged 4-12 years with unilateral amblyopia and comparison of retinal microvascular changes before and after 3
Sponsors
Maulana Azad Medical College and Associated Hospitals
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 4-12 years. 2.Patients with strabismic / anisometropic /sensory deprivation amblyopia. 3.Pseudophakic patients with clear visual axis
Exclusion criteria
Exclusion criteria: 1.Bilateral amblyopia 2.Ametropic amblyopia 3.Poor quality OCT-A scans 4.Poor fixation/ nystagmus/ uncooperative children 5.Children with spherical refractive errors of +/-5.00 diopters(D) or cylindrical refractive errors of 3.00 diopters(D) or greater. 6.Ocular diseases viz. corneal opacities, uveitis, retinal pathology. 7.History of prematurity. 8.History of neurological disease. 9.History of any systemic condition that could alter the retinal microvasculature (juvenile onset diabetes, renal disease, hypertension). 10.History of skin allergies and irritations with bandage-type occluders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T0 assess the retinal microvasculature in pre-treatment & post-treatment amblyopic eyes using following parameters in OCTA [Model: RS-3000 LITE advanced (NIDEK)]: â?¢Foveal Avascular Zone Measurements (FAZ) (mm2) â?¢Macular Vessel density percentage of SCP scan â?¢Macular Vessel density percentage of DCP scanTimepoint: 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the following parameters in pre-treatment & post-treatment amblyopic eyes using OCT (Model: REVO 60 Optipol) â?¢Central Macular thickness (µm) â?¢Peripapillary Retinal nerve fiber layer thickness (µm)Timepoint: 3 MONTHS | — |
Countries
India
Contacts
Public ContactMeghna Sethi
Maulana Azad Medical College
Outcome results
None listed